β-Amyloid Peptide and Amyloid Precursor Proteins in Olfactory Mucosa of Patients with Alzheimer's Disease,Parkinson's Disease,and down Syndrome

Abstract

Dystrophic neurites are present in olfactory epithelium (OE) of patients with Alzheimer's disease (AD), Parkinson's disease (PD), and Down syndrome (DS) and occasionally in normal individuals. Cultured olfactory neuroblasts from AD patients generate carboxy terminal amyloid precursor protein (APP) fragments that contain β-amyloid (Aβ), but it is not known if deposits of Aβ and/or APP fragments occur in the OE of individuals with or without AD, PD, or DS. To determine if Aβ accumulates in the OE in situ, we probed postmortem samples of olfactory mucosa from patients with AD, PD and AD (PD/AD), and DS and AD (DS/AD), as well as from controls, using polyclonal and monoclonal antibodies to Aβ and flanking sequences in APPs. Samples of OE also were examined by thioflavin-S and electron microscopy. Labeling of Aβ was observed in 10 of 12 AD cases, 2 of 3 PD/AD cases, 3 of 4 DS/AD cases, 3 of 10 adult controls, and 4 of 6 fetal cases. The Aβ staining was seen in the basal third of the OE, in axons projecting through the lamina propria, and in metaplastic respiratory epithelium within the OE. Antibodies to other APP domains stained the OE of patients and controls. Thioflavin-S staining was present in the basal third of the OE of 8 of 9 AD patients and several PD/AD and DS/AD patients, but only in rare cells of 3 controls. Electron microscopy did not reveal amyloid fibrils in the OE. These data suggest that deposition of Aβ occurs in a variety of circumstances and is not restricted to patients with AD, PD, or DS.

Keywords

Alzheimer's disease amyloid Down syndrome olfactory epithelium Parkinson's disease

Get full access to this article

View all access options for this article.

References

Doty

Reyes

Gregor

. Presence of both odor and identification deficits in Alzheimer's disease. Brain Res Bull 1987;18: 597–600.

Doty

Rikland

Deems

Reynolds

Stellar

. Olfactory and cognitive deficits of Parkinson's disease. Ann Neurol 1987;25: 166–71.

Talamo

Rudel

Kosik

. Pathology in olfactory neurons of Alzheimer's patients. Nature 1989;37: 736–9.

Trojanowski

Newman

Hill

Lee

VM-Y

. Human olfactory epithelium in normal aging, Alzheimer's disease, and other neurodegenerative disorders. J Comp Neurol 1991;310: 365–76.

Lee

Goedert

Hill

Lee

VM-Y

Trojanowski

. Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer's patients and developmentally regulated in human fetal spinal cord. Exp Neurol 1993;121: 93–105.

Wolozin

Bacic

Merril

. Differential expression of carboxy terminal derivatives of amyloid precursor protein among cell lines. J Neurosci Res 1992;33: 163–9.

Wolozin

Lesch

Lebovics

Sunderland

. Olfactory neuroblasts from Alzheimer donors: studies on APP processing and cell regulation. Biol Psychiatry 1993;34: 824–38.

Wolozin

Sunderland

Zheng

. Continuous culture of neuronal cells from adult human olfactory epithelium. J Mol Neurosci 1992;3: 137–46.

Wolozin

Zheng

Loren

. β/A4 domain of APP: antigenic differences between cell lines. J Neurosci Res 1992;33: 189–95.

10.

Arai

Higuchi

Matsushita

Yuzurih

Trojanowski

Lee

VM-Y

. Expression of β-amyloid precursor protein in the developing human spinal cord. Brain Res 1994;642: 132–6.

11.

Arai

Lee

VM-Y

Hill

Greenberg

Trojanowski

. Lewy bodies contain β-amyloid precursor proteins of Alzheimer's disease. Brain Res 1992;585: 386–90.

12.

Arai

Lee

VM-Y

Messinger

Greenberg

Lowery

Trojanowski

. Expression patterns of β-amyloid precursor protein (APP) in neural and non-neural human tissues from Alzheimer disease and control subjects. Ann Neurol 1991;30: 686–93.

13.

Arai

Lee

VM-Y

Otvos

Jr . Defined neurofilament, τ, and β-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc Natl Acad Sci USA 1990;87: 2249–53.

14.

Arai

Schmidt

Lee

VM-Y

. Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson's disease. Neurology 1992;42: 1315–22.

15.

Bickel

Lee

VM-Y

Trojanowski

Pardridge

. Targeting brain amyloid in Alzheimer's disease with a cationized monoclonal antibody against βA4 peptide. Bioconjugate Chem 1994;5: 119–25.

16.

Y-T

Woodruff-Pak

Trojanowski

. Amyloid plaques in cerebellar cortex and the integrity of Purkinje cell dendrites. Neurobiol Aging 1994;15: 1–9.

17.

Lowery

Pasternak

Gonzalez-DeWhit

. Alzheimer amyloid precursor protein produced by recombinant baculovirus expression: proteolytic processing and protease inhibitory properties. J Biol Chem 1991;266: 19842–50.

18.

Shin

R-W

Bramblett

Lee

VM-Y

Trojanowski

. Alzheimer's disease A68 proteins injected into rat brain induce co-deposits of β-amyloid, ubiquitin and α1-antichymotrypsin. Proc Natl Acad Sci USA 1993;90: 6825–8.

19.

Standaert

Lee

VM-Y

Greenberg

Lowery

Trojanowski

. Molecular features of hypothalamic plaques in Alzheimer's disease. Am J Pathol 1991;139: 681–91.

20.

Stern

Otvos

Jr Trojanowski

Lee

VM-Y

. Monoclonal antibodies to a synthetic peptide homologous with the first twenty-eight amino acids of Alzheimer's disease β-protein recognize amyloid and diverse glial and neuronal cell types in the central nervous system. Am J Pathol 1989;134: 973–8.

21.

Stern

Trojanowski

Lee

VM-Y

. Antibodies to the β-amyloid protein cross react with conformational epitopes in human fibrinogen subunits from peripheral blood. FEBS Lett 1990;264: 43–7.

22.

Wertkin

Turner

Pleasure

. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc Natl Acad Sci USA 1993;90: 9513–7.

23.

Kim

Wen

Bancher

. Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci Res Commun 1990;7: 113–22.

24.

Hyman

Tanzi

Marzloff

Barbour

Schenk

. Kunitz protease inhibitor-containing amyloid β protein precursor immunoreactivity in Alzheimer's disease. J Neuropathol Exp Neurol 1992;51: 76–83.

25.

Davies

Mann

DMA

. Is the “preamyloid” of diffuse plaques in Alzheimer's disease really nonfibrillar?. Am J Pathol 1993;143: 1594–605.

26.

Sprecher

Grant

Grimm

. Molecular cloning of the cDNA for a human amyloid precursor protein homologue: evidence for a multigene family. Biochemistry 1993;32: 4481–6.

27.

Wasco

Gurughagavatula

Paradis

. Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor. Nature Genet 1993;5: 95–100.

28.

Hardy

. Genetic mistakes point the way for Alzheimer's disease. J NIH Res 1993;5: 46–9.

29.

Mullan

Crawford

. Genetic and molecular advances in Alzheimer's disease. Trends Neurosci 1993;16: 398–403.

30.

Price

Bochelt

Sisodia

. Alzheimer disease and the prion disorders amyloid β-protein and prion protein amyloidoses. Proc Natl Acad Sci USA 1993;90: 6381–4.

31.

Selkoe

. Physiological production of the β-amyloid protein and the mechanisms of Alzheimer's disease. Trends Neurosci 1993;16: 403–9.

32.

Ohm

Braak

. Olfactory bulb changes in Alzheimer's disease. Acta Neuropathol (Berl) 1987;73: 365–9.

33.

Trojanowski

Schmidt

Shin

R-W

Bramblett

Goedert

Lee

VM-Y

. PHFτ (A68): from pathological marker to potential mediator of neuronal dysfunction and degeneration in Alzheimer's disease. Clin Neurosci 1993;1: 184–91.